Open Access Case study

A case report of human immunodeficiency virus-associated anaplastic lymphoma kinase protein-negative anaplastic large cell lymphoma

Hiroaki Taniai, Norihiro Furusyo*, Masayuki Murata, Fujiko Mitsumoto, Motohiro Shimizu, Kazuhiro Toyoda, Eiichi Ogawa, Mosaburo Kainuma, Kyoko Okada and Jun Hayashi

Author Affiliations

Department of General Internal Medicine, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-Ku, Fukuoka 812-8582, Japan

For all author emails, please log on.

SpringerPlus 2013, 2:400  doi:10.1186/2193-1801-2-400

Published: 23 August 2013

Abstract

Human immunodeficiency virus (HIV)-associated anaplastic large cell lymphoma (ALCL) is not so common, and anaplastic lymphoma kinase protein (ALK)-negative ALCL is rare and has a low survival rate. We report a case of a 31-year-old Japanese man diagnosed with HIV-associated ALK-negative ALCL who presented with long-lasting fever of unknown origin. The diagnosis was based on a full work-up that included inguinal lymph-node biopsy. Eight-cycle chemotherapy that included cyclophosphamide, doxorubicin, vincristine, and prednisone in addition to antiretroviral therapy for HIV infection provided a complete remission of his ALCL and over 5-year survival for him.

Keywords:
Human immunodeficiency virus; Anaplastic large cell lymphoma; Anaplastic lymphoma kinase